U.S. News: City of Hope Is Best Cancer Hospital in the West

July 29, 2019 | Letisia Marquez

City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.

Continue Reading

City of Hope lauded for lung, colon cancer surgery

August 12, 2019 | Abe Rosenberg

U.S. News & World Report, which recently named City of Hope the best cancer facility in the West, singled out the colon cancer surgery and lung cancer surgery divisions as “high performing.”

ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL

June 28, 2019 | City of Hope

At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.

Breakthrough drug shows results in lung, colon cancer

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Researchers detail new findings at 2019 AACR meeting

March 28, 2019 | Zen Vuong

City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

Australian patient travels 9,000 miles for a cure

March 7, 2019 | Michael Easterling

Australian lobster fisherman David Thompson traveled 9,000 miles for treatment at City of Hope after being diagnosed with Stage 4 oropharyngeal cancer. Given just six weeks to live, he is thriving more than a year after participating in an immunotherapy clinical trial.

The Changing Landscape of Lung Cancer Therapy

November 27, 2018 | City of Hope

City of Hope clinical trials reflect the rapidly changing landscape of lung cancer therapy. We continue to pioneer treatment in lung cancer with trials that incorporate biomarker testing and immunotherapy.